These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8977413)

  • 21. Differential regulation of pituitary hormone secretion and gene expression by thyrotropin-releasing hormone. A role for mitogen-activated protein kinase signaling cascade in rat pituitary GH3 cells.
    Kanasaki H; Yonehara T; Yamamoto H; Takeuchi Y; Fukunaga K; Takahashi K; Miyazaki K; Miyamoto E
    Biol Reprod; 2002 Jul; 67(1):107-13. PubMed ID: 12080005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct evidence that burst but not sustained secretion of prolactin stimulated by thyrotropin-releasing hormone is dependent on elevation of cytoplasmic calcium.
    Kolesnick RN; Gershengorn MC
    J Biol Chem; 1985 May; 260(9):5217-20. PubMed ID: 3921543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target cells of gamma3-melanocyte-stimulating hormone detected through intracellular Ca2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage.
    Roudbaraki M; Lorsignol A; Langouche L; Callewaert G; Vankelecom H; Denef C
    Endocrinology; 1999 Oct; 140(10):4874-85. PubMed ID: 10499547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that cobalt ion inhibition of prolactin secretion occurs at an intracellular locus.
    Thaw CN; Raaka EG; Gershengorn MC
    Am J Physiol; 1984 Sep; 247(3 Pt 1):C150-5. PubMed ID: 6089572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin-releasing hormone-induced intracellular calcium responses in individual rat lactotrophs and thyrotrophs.
    Ashworth R; Hinkle PM
    Endocrinology; 1996 Dec; 137(12):5205-12. PubMed ID: 8940336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium influx is not required for TRH to elevate free cytoplasmic calcium in GH3 cells.
    Gershengorn MC; Thaw C
    Endocrinology; 1983 Oct; 113(4):1522-4. PubMed ID: 6413196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro.
    Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA
    Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells.
    Yang JP; Tashjian AH
    Biochem Biophys Res Commun; 1991 Jan; 174(2):424-31. PubMed ID: 1847044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
    Coleman DT; Chen X; Sassaroli M; Bancroft C
    Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C.
    Shupnik MA; Weck J; Hinkle PM
    Mol Endocrinol; 1996 Jan; 10(1):90-9. PubMed ID: 8838148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follistatin, induced by thyrotropin-releasing hormone (TRH), plays no role in prolactin expression but affects gonadotropin FSHbeta expression as a paracrine factor in pituitary somatolactotroph GH3 cells.
    Oride A; Kanasaki H; Purwana IN; Mutiara S; Miyazaki K
    Regul Pept; 2009 Aug; 156(1-3):65-71. PubMed ID: 19446581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
    Ramsdell JS; Tashjian AH
    Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.
    Casanueva FF; Villanueva L; Dieguez C; Diaz Y; Cabranes JA; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
    J Clin Endocrinol Metab; 1987 Oct; 65(4):634-42. PubMed ID: 2888782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
    Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW
    Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroliberin action in pituitary cells is not inhibited by pertussis toxin.
    Hinkle PM; Hewlett EL; Gershengorn MC
    Biochem J; 1986 Jul; 237(1):181-6. PubMed ID: 3026309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.